Adelina Lear of contract research organization ICON plc spoke at SlatorCon London on the role of language services and the linguistic validation workflow in clinical trials. Continue reading
Slator’s inaugural comprehensive language industry market report. It examines total market size, the 10 main end-buyer industries, competitive landscape, productivity tech, NMT and much more. Continue reading
On the back of a 16.9% growth YOY of its core Translation Business, Honyaku Center posts USD 78.68m in revenues for the first 9 months of its 2019 fiscal year. Continue reading
As TransPerfect posts USD 705m in full-year revenues for 2018, CEO Phil Shawe comments on the company’s record setting 2018, his M&A outlook for 2019, neural machine translation, and why Amazon... Continue reading
SlatorCon tour took in four global cities across three continents in 2018 and featured a grand total of 35 speakers representing the full breadth of the language industry from startups, language... Continue reading
Pharma and biotech giant Roche’s Claudine Nick outlined the internal and external complexities of localizing for this highly regulated industry and highlighted the value-add of having an internal... Continue reading
Language service provider RWS tells investors at capital markets event about how it is integrating Moravia and informs about the results of a pilot project to deploy MT post-editing in production... Continue reading
Partnership will streamline the international medical labeling publishing process Continue reading
As technology is boosting productivity and changing buyer expectations, dropping unit prices presents opportunities to vendors that bring the tech, specialization, and size to seize them but it... Continue reading
Slator poll-takers say life sciences is the most high-growth vertical, share very positive outlook on neural MT, reveal word rate changes in 2017, and answer whether LSPs should build or buy... Continue reading
AMPLEXOR'S Jason Arnsparger will present “Lost in Translation: The Case for Centralized Content Management" at the Pharma & Device Labeling Conference. Continue reading
Hydrocortisone or Dexamethasone? A Guangdong-based Chinese drug manufacturer gets a warning letter from the US Food and Drug Administration over a translation mistake in the label of an... Continue reading
The acquisition of LUZ, Inc. and Corporate Translations, Inc. strengthens RWS’ market leadership and continued growth of life science language services. Continue reading
The combination of ICON’s and Mapi’s language services groups will create a potent rival to language service providers when competing for business with big pharma. Continue reading
With new regulations in China as well as global language issues, life sciences companies are facing new challenges in conducting clinical trials in Asia-Pacific. Continue reading
This information will never be shared with third parties. No Spam.